Share Price and Basic Stock Data
Last Updated: November 19, 2025, 11:13 pm
| PEG Ratio | -1.44 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Ambo Agritec Ltd operates within the Edible Oils & Solvent Extraction industry, with its shares currently priced at ₹48.1 and a market capitalization of ₹95.5 Cr. The company’s revenue has shown a fluctuating trend over the years, with sales reported at ₹81 Cr in FY 2023, increasing to ₹101 Cr in FY 2024. Projections for FY 2025 stand at ₹120 Cr, indicating a compound annual growth rate (CAGR) that could appeal to investors. Quarterly sales figures reveal a seasonal pattern, with ₹42 Cr recorded in September 2023, rising to ₹59 Cr by March 2024, before experiencing a slight decline to ₹52 Cr in September 2024. Overall, the revenue trajectory reflects a recovery from the FY 2021 low of ₹47 Cr, but the volatility in quarterly figures suggests the company faces challenges in maintaining consistent growth.
Profitability and Efficiency Metrics
Ambo Agritec’s profitability metrics indicate a mixed performance. The operating profit margin (OPM) stood at 0% for FY 2024, contrasting sharply with an OPM of 3% in FY 2023, suggesting operational inefficiencies. For the recent quarters, OPM fluctuated between 2% to 5%, with a notable decline to 0% anticipated for March 2025. Net profit figures also reflect this instability, with ₹1 Cr recorded in both September 2023 and FY 2023, but dropping to ₹0 Cr by March 2025. The interest coverage ratio (ICR) of 2.36x indicates that the company can cover its interest obligations comfortably, albeit with limited profitability. Additionally, the return on equity (ROE) at 6.24% and return on capital employed (ROCE) at 10% are low compared to industry standards, suggesting room for improvement in capital utilization and operational efficiency.
Balance Sheet Strength and Financial Ratios
Ambo Agritec’s balance sheet reflects a conservative financial structure, with no reported borrowings, which positions the company favorably in terms of financial leverage. The current ratio of 2.94x indicates strong liquidity, allowing the company to meet short-term obligations effectively. However, the price-to-book value (P/BV) ratio stands at 2.91x, suggesting that the stock is trading at a premium relative to its book value, which could deter value-focused investors. The working capital days have increased significantly to 133 days in FY 2025, raising concerns about inventory management and cash flow efficiency. Moreover, the company’s asset turnover ratio of 2.21% is relatively low, highlighting inefficiencies in utilizing its assets to generate revenue. Overall, while the balance sheet appears robust, the operational metrics point towards challenges that could affect long-term sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Ambo Agritec reveals significant shifts in ownership dynamics. Promoters held a substantial 63.80% stake as of March 2024, but this has declined to 61.05% by March 2025, reflecting a gradual dilution of control. Conversely, public ownership has increased from 36.11% in March 2023 to 50.70% by September 2025, indicating growing interest from retail investors. The presence of foreign institutional investors (FIIs) remains negligible at 0.00%, which may reflect a lack of confidence in the company’s growth prospects. With only 393 shareholders reported as of September 2025, the company faces the challenge of broadening its investor base. This evolving shareholding pattern may influence market perception and investor confidence, with retail investors potentially driving demand if performance improves.
Outlook, Risks, and Final Insight
Looking ahead, Ambo Agritec faces both opportunities and risks that could shape its future. The potential for revenue growth is evident, with a projected increase to ₹120 Cr in FY 2025, but operational inefficiencies and fluctuating profitability metrics pose significant risks. The company’s high cash conversion cycle of 119 days raises concerns regarding liquidity and inventory management, which could impact cash flows. Additionally, the declining promoter stake could signal reduced confidence among insiders, potentially influencing market sentiment. For Ambo Agritec to enhance its attractiveness to investors, it must focus on improving operational efficiency, stabilizing profitability, and effectively managing its working capital. A strategic approach to these areas may lead to a more favorable outlook, positioning the company for growth in a competitive industry landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Ambo Agritec Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IEL Ltd | 104 Cr. | 7.94 | 10.3/3.87 | 3.37 | 0.00 % | 2.51 % | 1.91 % | 1.00 | |
| Evexia Lifecare Ltd | 315 Cr. | 1.68 | 4.40/1.52 | 221 | 3.02 | 0.00 % | 0.30 % | 0.32 % | 1.00 |
| Diligent Industries Ltd | 65.6 Cr. | 2.75 | 5.12/1.45 | 25.5 | 2.79 | 0.00 % | 7.06 % | 6.09 % | 1.00 |
| CIAN Agro Industries & Infrastructure Ltd | 3,862 Cr. | 1,380 | 3,633/321 | 1,903 | 33.0 | 0.00 % | 8.54 % | 1.06 % | 10.0 |
| BCL Industries Ltd | 1,054 Cr. | 35.8 | 58.3/33.0 | 10.1 | 28.9 | 0.73 % | 13.2 % | 13.0 % | 1.00 |
| Industry Average | 10,816.29 Cr | 171.90 | 158.12 | 33.80 | 0.18% | 14.09% | 12.05% | 4.00 |
Quarterly Result
| Metric | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales | 42 | 59 | 52 | 68 |
| Expenses | 40 | 58 | 49 | 68 |
| Operating Profit | 1 | 1 | 3 | 0 |
| OPM % | 4% | 2% | 5% | 0% |
| Other Income | 0 | 1 | 0 | 2 |
| Interest | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 1 | 2 | 1 |
| Tax % | 25% | 31% | 25% | 52% |
| Net Profit | 1 | 1 | 1 | 0 |
| EPS in Rs | 0.57 | 0.92 | 1.26 | 0.33 |
Last Updated: May 31, 2025, 7:02 am
Below is a detailed analysis of the quarterly data for Ambo Agritec Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 16.00 Cr..
- For Expenses, as of Mar 2025, the value is 68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 49.00 Cr. (Sep 2024) to 68.00 Cr., marking an increase of 19.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Sep 2024) to 0.00%, marking a decrease of 5.00%.
- For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Mar 2025, the value is 52.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 52.00%, marking an increase of 27.00%.
- For Net Profit, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Sep 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.33. The value appears to be declining and may need further review. It has decreased from 1.26 (Sep 2024) to 0.33, marking a decrease of 0.93.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 3:01 pm
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Sales | 63 | 73 | 47 | 95 | 81 | 101 | 120 |
| Expenses | 62 | 73 | 46 | 92 | 78 | 98 | 117 |
| Operating Profit | 1 | 0 | 1 | 3 | 2 | 3 | 3 |
| OPM % | 2% | 1% | 3% | 3% | 3% | 3% | 2% |
| Other Income | 1 | 1 | 0 | 0 | 1 | 1 | 2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 2 | 2 | 2 | 3 |
| Tax % | 16% | -10% | 34% | 38% | 25% | 28% | 35% |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 1 | 2 |
| EPS in Rs | 24.60 | 18.31 | 10.87 | 68.08 | 1.26 | 1.49 | 1.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% |
Ambo Agritec Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 3 years from 2022-2023 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 8% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 43% |
| 3 Years: | 17% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -56% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 2:16 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 25 | 21 | 12 | 62 | 45 | 74 |
| Inventory Days | 69 | 52 | 88 | 56 | 73 | 80 | 65 |
| Days Payable | 41 | 37 | 54 | 17 | 30 | 23 | 20 |
| Cash Conversion Cycle | 47 | 41 | 55 | 51 | 105 | 102 | 119 |
| Working Capital Days | 13 | 11 | 31 | 5 | 71 | 59 | 133 |
| ROCE % | 11% | 10% | 21% | 13% | 11% | 10% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.10 | 1.45 |
| Diluted EPS (Rs.) | 1.10 | 1.45 |
| Cash EPS (Rs.) | 0.90 | 1.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 28.68 | 19.45 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 28.68 | 19.45 |
| Revenue From Operations / Share (Rs.) | 81.30 | 107.62 |
| PBDIT / Share (Rs.) | 2.75 | 3.77 |
| PBIT / Share (Rs.) | 2.68 | 3.68 |
| PBT / Share (Rs.) | 1.51 | 2.05 |
| Net Profit / Share (Rs.) | 0.82 | 1.45 |
| NP After MI And SOA / Share (Rs.) | 0.83 | 1.45 |
| PBDIT Margin (%) | 3.38 | 3.50 |
| PBIT Margin (%) | 3.29 | 3.41 |
| PBT Margin (%) | 1.85 | 1.90 |
| Net Profit Margin (%) | 1.01 | 1.35 |
| NP After MI And SOA Margin (%) | 1.02 | 1.35 |
| Return on Networth / Equity (%) | 2.91 | 7.47 |
| Return on Capital Employeed (%) | 8.84 | 15.61 |
| Return On Assets (%) | 1.83 | 3.30 |
| Long Term Debt / Equity (X) | 0.04 | 0.12 |
| Total Debt / Equity (X) | 0.38 | 0.80 |
| Asset Turnover Ratio (%) | 2.21 | 0.00 |
| Current Ratio (X) | 2.94 | 1.85 |
| Quick Ratio (X) | 2.07 | 0.79 |
| Inventory Turnover Ratio (X) | 6.03 | 0.00 |
| Interest Coverage Ratio (X) | 2.36 | 2.32 |
| Interest Coverage Ratio (Post Tax) (X) | 1.71 | 1.89 |
| Enterprise Value (Cr.) | 138.76 | 36.09 |
| EV / Net Operating Revenue (X) | 1.16 | 0.35 |
| EV / EBITDA (X) | 34.22 | 10.18 |
| MarketCap / Net Operating Revenue (X) | 1.03 | 0.21 |
| Price / BV (X) | 2.91 | 1.18 |
| Price / Net Operating Revenue (X) | 1.03 | 0.21 |
| EarningsYield | 0.01 | 0.06 |
After reviewing the key financial ratios for Ambo Agritec Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 24) to 1.10, marking a decrease of 0.35.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has decreased from 1.45 (Mar 24) to 1.10, marking a decrease of 0.35.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 0.90, marking a decrease of 0.65.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.68. It has increased from 19.45 (Mar 24) to 28.68, marking an increase of 9.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 28.68. It has increased from 19.45 (Mar 24) to 28.68, marking an increase of 9.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 81.30. It has decreased from 107.62 (Mar 24) to 81.30, marking a decrease of 26.32.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 2.75. This value is within the healthy range. It has decreased from 3.77 (Mar 24) to 2.75, marking a decrease of 1.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 2.68. This value is within the healthy range. It has decreased from 3.68 (Mar 24) to 2.68, marking a decrease of 1.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 2.05 (Mar 24) to 1.51, marking a decrease of 0.54.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 2. It has decreased from 1.45 (Mar 24) to 0.82, marking a decrease of 0.63.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 2. It has decreased from 1.45 (Mar 24) to 0.83, marking a decrease of 0.62.
- For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has decreased from 3.50 (Mar 24) to 3.38, marking a decrease of 0.12.
- For PBIT Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 3.41 (Mar 24) to 3.29, marking a decrease of 0.12.
- For PBT Margin (%), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 10. It has decreased from 1.90 (Mar 24) to 1.85, marking a decrease of 0.05.
- For Net Profit Margin (%), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 5. It has decreased from 1.35 (Mar 24) to 1.01, marking a decrease of 0.34.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.02. This value is below the healthy minimum of 8. It has decreased from 1.35 (Mar 24) to 1.02, marking a decrease of 0.33.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.91. This value is below the healthy minimum of 15. It has decreased from 7.47 (Mar 24) to 2.91, marking a decrease of 4.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.84. This value is below the healthy minimum of 10. It has decreased from 15.61 (Mar 24) to 8.84, marking a decrease of 6.77.
- For Return On Assets (%), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 5. It has decreased from 3.30 (Mar 24) to 1.83, marking a decrease of 1.47.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.04, marking a decrease of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.38. This value is within the healthy range. It has decreased from 0.80 (Mar 24) to 0.38, marking a decrease of 0.42.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.21. It has increased from 0.00 (Mar 24) to 2.21, marking an increase of 2.21.
- For Current Ratio (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 2.94, marking an increase of 1.09.
- For Quick Ratio (X), as of Mar 25, the value is 2.07. This value exceeds the healthy maximum of 2. It has increased from 0.79 (Mar 24) to 2.07, marking an increase of 1.28.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.03. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 6.03, marking an increase of 6.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 3. It has increased from 2.32 (Mar 24) to 2.36, marking an increase of 0.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.71. This value is below the healthy minimum of 3. It has decreased from 1.89 (Mar 24) to 1.71, marking a decrease of 0.18.
- For Enterprise Value (Cr.), as of Mar 25, the value is 138.76. It has increased from 36.09 (Mar 24) to 138.76, marking an increase of 102.67.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has increased from 0.35 (Mar 24) to 1.16, marking an increase of 0.81.
- For EV / EBITDA (X), as of Mar 25, the value is 34.22. This value exceeds the healthy maximum of 15. It has increased from 10.18 (Mar 24) to 34.22, marking an increase of 24.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 1.03, marking an increase of 0.82.
- For Price / BV (X), as of Mar 25, the value is 2.91. This value is within the healthy range. It has increased from 1.18 (Mar 24) to 2.91, marking an increase of 1.73.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 1.03, marking an increase of 0.82.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambo Agritec Ltd:
- Net Profit Margin: 1.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.84% (Industry Average ROCE: 14.09%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.91% (Industry Average ROE: 12.05%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 50 (Industry average Stock P/E: 158.12)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Edible Oils & Solvent Extraction | 3 Pretoria Street, Kolkata West Bengal 700071 | info@amboasritec.com www.amboagritec.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Umesh Kumar Agarwal | Managing Director |
| Mr. Saikat Chatterjee | Executive Director |
| Mr. Rang Nath Lahoti | Executive Director |
| Mrs. Geetanjali Saberwal Agarwal | Non Executive Director |
| Mr. Ashok Kumar Singh | Independent Director |
| Mr. Tapas Sankar Chattopadhyay | Independent Director |